Journal of Food Bioactives, ISSN 2637-8752 print, 2637-8779 online
Journal website www.isnff-jfb.com

Review

Volume 17, March 2022, pages 6-10


Cinnamon: an immune modulator food additive to coronavirus

Ravindra Vermaa, *, Prakash S. Bisenb

aSchool of Studies in Biotechnology, Jiwaji University, Gwalior 474001, India
bHonorary Emeritus Professor, School of Studies in Biotechnology, Jiwaji University, Gwalior 474001, India
*Corresponding author: Ravindra Verma, School of Studies in Biotechnology, Jiwaji University, Gwalior 474001, India. Tel: 91-11-7999212685; E-mail: vermaravindra917@gmail.com
DOI: 10.31665/JFB.2022.17298

Received: February 3, 2022
Revised received & accepted: March 8, 2022

Abstract▴Top 

This study explores the potential role of cinnamaldehyde from cinnamon to elicit immunity against the pathogens of COVID-19. In the culture of traditional and herbal treatments, it was more valuable than gold. It has been observed that coronavirus infects cells of an organism including innate and adaptive immune cells. Cinnamaldehyde, eugenol, and other secondary metabolism of cinnamon extract, have a potential role to interact with spike protein of coronavirus. Available literature supports the suitability of cinnamon for acute respiratory infectious disease syndromes. It might be a promising source for the immune system to control viral infections like COVID-19. Preclinical and clinical trials are necessary for the safety and efficacy of the drug.

Keywords: Cinnamon; Coronavirus, COVID-19; Immunity; SARS-CoV-2

1. Introduction▴Top 

This communication is focused on the health benefits of the extracts of secondary metabolism of the compound found in cinnamon, a wonder herb for COVID-19 patients. Due to high mutation rates of SARS-CoV-2 spike protein may rise to variant of concern (VOC). Therefore, it can evade the vaccine-induced acquired immunity. Phytochemicals are considered as an effective alternative for treatment of COVID-19 infection (Chen, Wang, Wang and Wei, 2020; Jena et al., 2021; Nag et al., 2021). There are several significant risk factors for severe COVID-19 infection, such as diabetes mellitus, chronic lung disease, cardiovascular disease (CVD), obesity, and a range of other illnesses that make the patient immune compromised (Zabetakis et al., 2020; Gasmi et al., 2021). An intimate relationship exists between the immune system and the metabolic response system. The metabolic and immune systems are essential to survival (Hotamisligil, 2006). Inflammation is a flow of information in response to infection. When tissue is injured, the basic challenge for the host is to detect whether infection is present. In the event of injury and infection, a quick response is required to stop the spread of infection, even at the cost of additional tissue damage. Repairing damaged tissue caused by inflammation or that inflammation damaged is necessary (Nathan, 2002).

Our objective is to explore the potential role of cinnamon to elicit an immune response in the pathogenesis of COVID-19. For the development of this literature, an extensive database search was carried out using scientific databases like MEDLINE, BIOSIS, PubMed, EMBASE, Mendeley database, TOXLINE, and Google Scholar, Google, Google Patent. After careful examination of the literature, we consider only those literatures that fit within the scope of our target.

2. Cinnamon may be immunity booster agent for Covid-19 patients▴Top 

Cinnamon, a tree of the Lauraceae family, grows up to the height of 10–15 meters. In our traditional culture of herbal treatment, it was more valuable than gold, commonly used in kitchens. There is suitable evidence that confirmed that cinnamon was used in the treatment of influenza and several related diseases (Ross 1906). Phytochemicals study of cinnamon identified 2- propenal, 3-phenyl (trans-cinnamaldehyde-87.013%), and Eugenol (9.317%), as major compounds. While other important phytochemicals are identified as Tricyclo [3.3.1.0 (2,8)] nona-3,6- dien-9-on (0.173%), O-Methoxy cinnamic aldehyde (0.236%), α-muurolene (0.133%), Naphthalene, 1,2,3,4-tetrahydro-1,6-dime (0.195%) (Adinew, 2014). SARS-CoV-2 infection is associated with respiratory disease, and being a new strain, the pathogenesis of disease causation is not fully known. The interlocking of spike (S) glycoprotein with angiotensin-converting enzyme 2 (ACE2) receptor is the only donor to enter in the cells. Coronavirus infects all cells of an organism including inherent and adaptive immune cells. Coronavirus mostly affects the alveolar epithelial cells of the lungs and enterocytes of the small intestine in the initial phase (Singh et al., 2020). Infected cells release cytokines that initiate protective immunity against SARS-CoV-2. Macrophages (B lymphocytes and T lymphocytes) are immune cells that recognize viruses. Interleukin (IL2 and IL6), interferon (IFN), and tumor necrosis factor-α (TNF-α) play a critical role in Covid-19 inflammation, modulating the immune response and causing acute respiratory distress syndrome (ARDS), and multiorgan failure. Researchers confirmed that respiratory virus infection damages free radicals (Vallyathan and Shi, 1997).

The innate immune system acts as the first line of defence, while the adaptive immune system destroys foreign pathogens like viruses, bacteria, or unwanted particles. The main organs affected by Covid 19 infection are the lungs due to collapse of alveoli, diffuse alveolar damage, destruction of alveolar epithelial cells, and formation of hyaline membranes (Carsana et al., 2020 ; Thimmulappa et al., 2021). In moderate patients, recovery depends only on the development of antibodies and the activation of the immune response (Thimmulappa et al., 2021). An antibody is a Y-shaped protein that binds to the spike (S) protein of the coronavirus and acts as a messenger for the adaptive immune system (Chen et al., 2021). It is necessary to understand how the Coronavirus infects our respiratory tract and transforms into a number of cells. As the Coronavirus invades the respiratory section of the body, its spike (S) protein couples to the receptor of angiotensin-converting enzyme 2 (ACE2-enzyme) on the alveolar cell membrane and transfers its RNA into the host cells. Due to massive viral load and the mRNA of SARS-CoV-2 combined with other cells and respiratory tract infection, the cells defused. In response to SARS-CoV-2, the immune system triggers several immune responses such as interferon (IFN)-γ, Interferon gamma-inducible protein (IP-10), monocyte chemotactic protein-1 (MCP-1), tumor necrosis factor (TNF)-α, interleukin (IL)-6, and IL-1β (Esmaeilzadeh and Elahi, 2021). Virus pathogens activate the innate immune system. Adaptive immunity plays a crucial role in viral infections. The most effective adaptive immune systems are B cells (the source of antibodies, CD4+ T cells, and CD8+ T cells) (Sette and Crotty, 2021). As a result of the innate immune response, the body’s secondary or acquired immune system develops antibodies to attach to the spike-protein and neutralize the virus. Macrophages, a segment of the immune system, damage the virus cells in bulk (Kasuga et al., 2021). Functional foods increase NK cell activity, regulate cytokines specific to Th17 (RORc, IL-17A), and Th2 (IL-5, IL-13, and IL-6) immune responses, suppress IL-6, IL-1β, RORc, IL-17A, TNF-α secretion, and add to IL-10, INF-γ secretion. The research confirmed the role of food additives as immune-modulators and immune-boosters in inflammation (Gautam et al., 2020; Han et al., 2021). In a recent study on immune response, it was demonstrated that IL-6 receptors play a significant role in the trans-signaling treatment of COVID-19 cytokine storm syndrome (Chen et al., 2020). To revive the patient’s health, the only prospective therapy is immune response activation against SARS-CoV-2. SARS-CoV-2 infection can be overcome by intracellular signaling pathways that modulate host immunity, and this is an area of great interest for drug development (Catanzaro et al., 2020). “Cytokine storm” in host defence is a result of excessive immune responses caused by SARS-CoV-2. Overload of free radicals is known as oxidative stress, developing chronic and degenerative diseases. This can only be rectified by antioxidants, which are produced naturally in the body or through food supplements (Pham-Huy et al, 2008; Rao and Gan, 2014). Nitric oxide (NO), plays a dominant role in both the cardiopulmonary and immune defence systems (Fang et al., 2021). Trans-cinnamaldehyde (TCA) suppresses the production of NO, modulates the expression of iNOS, IL-1β, and induces NF-κB inactivation (Fu et al., 2017; Lucas et al 2021). Cinnamaldehyde is a standard chemical allergen, which increases the histamine release, and cell-mediated Immunity (Badger-Emeka et al., 2020). The details of important phytocompounds and their interaction with coronavirus and immunity is mentioned in Table 1.


Click to view
Table 1.

Important phytocompounds of cinnamon and their interaction with coronavirus and immune system
 

The cytokine profiles observed in covid-19 patients are activation of macrophages with high production of IL-6, IL-7, TNF and inflammatory chemokines like CC-chemokine ligand 2 (CCL2), CCL3 and CXC-chemokine ligand 10 (CXCL10). This observation confirms the dysregulation of mononuclear phagocyte contribution in hyper inflammation (Merad and Martin, 2020, Tay et al., 2020).

Trans-cinnamaldehyde (TCA), a principal constituent in cinnamon, has the potential to reduce the maturation of influenza A/PR/8 virus in bronchoalveolar lavage fluid. These findings support the suitability of the empirical indication of Cinnamomi cortex-containing herbal formulations for acute respiratory infectious diseases (Hayashi et al., 2007). Phenolic compounds of Cinnamomum zeylanicum like caffeic acid (IC50 = 84%) and cinnamic acid (IC50 = 53%) had the most enzyme inhibition potential. Angiotensin-converting enzyme (ACE2) and type 2 transmembrane serine protease (TMPRSS2) are the target cell contributors in SARS-CoV-2 infection (Shahwar et al., 2012; Amawi et al., 2020; Prasanth et al., 2020). The water extract of cinnamon (CWE) substantially reduced the secretion of TNF-α and IL-6 and induced macrophages, and a substantial decrease in its mRNA expression was observed (Kunnumakkara et al., 2021). Another study confirms the moderate effects of butanol fraction (containing procyanidin A2 and procyanidin B1) on Cinnamomi Cortex (CC/Fr. 2) on antiviral activity against HIV/SARS-CoV S pseudo virus infections (Zhuang et al., 2009). Researchers have noted that procyanidin type A compound (IND02) derived from cinnamon has the potential to inhibit SARS-CoV-2 at the early phase of viral infection, because of its propinquity toward ACE2 receptor and binding glycans on the spike protein of SARS-CoV2 (Ghosh, 2020). Free radical induced immunosuppression contributes to the pathogenesis of viral infection and expansion of viral pathogens. Cinnamaldehyde possesses anti-inflammatory properties. It is perceived that cinnamaldehyde suppressed NF-κB activation and inhibits the TNF-α-induced inflammation. It also suppresses hyper-expression of Toll-like receptors (TLRs) and cytosolic sensor NOD-like receptors (NLRs), PYD domain-containing protein 3 (NLRP3) inflammasome signalling pathways (Liao et al., 2008; Lee et al., 2018). Cinnamaldehyde modulates the production of prostaglandins (PGEs) by reducing IL-1β-induced COX-2 activity (Guo et al., 2006). Scientific evidence confirms that cinnamon is a potential anti-inflammatory, antioxidant functional food and could be useful in mitigation of SARS-CoV-2 induced hyper inflammation. There is an increasing demand among covid-19 patients towards the consumption of cinnamon powder as preventive functional food against SARS-CoV-2 in the developing and developed world including India.

Another important phytocompound is eugenol, which has good oral bioavailability, seen as a promising agent for the development of drugs to treat SARS-CoV-2 infection (Tallei et al., 2020). The anti-hepatitis-c antibody activity of eugenol against HSV-1(F) and HSV was strong (Tragoolpua and Jatisatienr, 2007). Combination of eugenol and acyclovir supported the inhibited herpes virus replication in vitro. It has been studied that eugenol delays the growth of herpes virus induced keratitis (Benencia and Courreges, 2000). Recent study observed that eugenol interlinked with spike (S1) protein of SARS-CoV-2 and strongly suppressed the entry of pseudo-type SARS-CoV-2 into human ACE2- expressing HEK293 cells. They also noticed that eugenol modulates NF-kB, IL-6, IL-1β and TNFα in human A549 lung cells (Paidi et al., 2021). Inhibiting the main 3-chymotrypsin-like protease (3CLpro), also called Nsp5 (non-structural protein 5) is the fundamental strategy for coronavirus. (Rizzuti et al., 2021), reported that eugenol inhibits the enzymatic activity of 3CLpro.

Camphor has an excellent bond against protease of SARS-CoV-2 and ACE2 receptors (Omar et al., 2020). Camphor is a solid bicyclic organic compound derived from the cinnamon tree. Camphor improves catalase and Nrf-2 activities, and reduces NO, TNF-α, TLR4 serum levels in the covid-19 infections (Salama et al., 2021). In the traditional system of medicine, camphor was applied to the neck and chest skin for cough problems. It is also used as steam inhalation in the form of aerosol to prevent coughing (Pappas and Hendley, 2011; Eccles, 1994). Reddy et al., (2004), demonstrated the inhibition of NFkB by the cinnamon ingredients in human macrophages. A study examining the cinnamyl acetate suppression of NFκB inflammatory signaling in endothelial cells has confirmed the suppression of TNFα-induced p65 translocation (Liao et al., 2008). Another study concluded that dietary administration of cinnamyl acetate inhibited NF-κB activation through the ERK and p38 MAPK pathways in the mouse (Kim et al., 2007). Papain-Like cysteine protease (PLpro, NSP3) is required for coronavirus replication and a promising agent for antiviral drugs (Rut et al., 2020). These phytocompounds substantially act on viral main protease of SARS-CoV-2. On the basis of available literature, cinnamon inhibits the main protease of covid-19 and can be a potential drug candidate as an immunity booster.

3. Conclusion▴Top 

Plenty of scientific literature confirms the antiviral and immunomodulatory potential of cinnamon extracts for influenza. Cinnamaldehyde and eugenol are effective antiviral agents and interact with spike protein of coronavirus. Cinnamon might be a promising source for the immune system to control viral infections like SARS-CoV-2. Functional food and food additives have the potential to elicit immunity against covid-19 infection and post-covid-19 care. Further preclinical and clinical trials are necessary to evaluate the efficacy level of major constituents of cinnamon extract as antiviral drugs.

Acknowledgments

None.

Conflict of interest

The authors confirm that this article’s content has no conflicts of interest.

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.


References▴Top 
Adinew, B. (2014). GC-MS and FT-IR analysis of constituents of essential oil from Cinnamon bark growing in South-west of Ethiopia. Int. J. Herb. Med. 1(6): 22–31.
Amawi, H., Abu Deiab, G.I., A Aljabali, A.A., Dua, K., and Tambuwala, M.M. (2020). COVID-19 pandemic: an overview of epidemiology, pathogenesis, diagnostics and potential vaccines and therapeutics. Ther. Deliv. 11(4): 245–268.
Badger-Emeka, L.I., Emeka, P.M., Thirugnanasambantham, K., and Ibrahim, H.I.M. (2020). Anti-Allergic Potential of Cinnamaldehyde via the Inhibitory Effect of Histidine Decarboxylase (HDC) Producing Klebsiella pneumonia. Molecules 25(23): 5580.
Benencia, F., and Courreges, M.C. (2000). In vitro and in vivo activity of eugenol on human herpesvirus. Phytother. Res. 14(7): 495–500.
Cabello, C.M., Bair, W.B. 3rd, Lamore, S.D., Ley, S., Bause, A.S., Azimian, S., and Wondrak, G.T. (2009). The cinnamon-derived Michael acceptor cinnamic aldehyde impairs melanoma cell proliferation, invasiveness, and tumor growth. Free Radic. Biol. Med. 46(2): 220–231.
Carsana, L., Sonzogni, A., Nasr, A., Rossi, R.S., Pellegrinelli, A., Zerbi, P., Rech, R., Colombo, R., Antinori, S., Corbellino, M., Galli, M., Catena, E., Tosoni, A., Gianatti, A., and Nebuloni, M. (2020). Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study. Lancet Infect. Dis. 20(10): 1135–1140.
Catanzaro, M., Fagiani, F., Racchi, M., Corsini, E., Govoni, S., and Lanni, C. (2020). Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2. Signal. Transduct. Target Ther. 5(1): 84.
Chen, J., Gao, K., Wang, R., and Wei, G.W. (2021). Prediction and mitigation of mutation threats to COVID-19 vaccines and antibody therapies. Chem Sci 12(20): 6929–6948.
Chen, J., Wang, R., Wang, M., and Wei, G.W. (2020). Mutations strengthened SARS-CoV-2 infectivity. J. Mol. Biol. 432(19): 5212–5226.
Chen, L., Hu, C., Hood, M., Zhang, X., Zhang, L., Kan, J., and Du, J. (2020). A novel combination of vitamin C, curcumin and glycyrrhizic acid potentially regulates immune and inflammatory response associated with coronavirus infections: a perspective from system biology analysis. Nutrients 12(4): 1193.
Eccles, R. (1994). Menthol and related cooling compounds. J. Pharm. Pharmacol. 46(8): 618–630.
Esmaeilzadeh, A., and Elahi, R. (2021). Immunobiology and immunotherapy of COVID-19: A clinically updated overview. J. Cell Physiol. 236(4): 2519–2543.
Fang, W., Jiang, J., Su, L., Shu, T., Liu, H., Lai, S., Ghiladi, R.A., and Wang, J. (2021). The role of NO in COVID-19 and potential therapeutic strategies. Free Radic. Biol. Med. 163: 153–162.
Fu, Y., Yang, P., Zhao, Y., Zhang, L., Zhang, Z., Dong, X., Wu, Z., Xu, Y., and Chen, Y. (2017). trans-Cinnamaldehyde inhibits microglial activation and improves neuronal survival against neuroinflammation in BV2 microglial cells with lipopolysaccharide stimulation. Evid. Based Complement. Alternat. Med. 2017: 4730878.
Gasmi, A., Peana, M., Pivina, L., Srinath, S., Gasmi Benahmed, A., Semenova, Y., Menzel, A., Dadar, M., and Bjørklund, G. (2021). Interrelations between COVID-19 and other disorders. Clin. Immunol. 224: 108651.
Gautam, S., Gautam, A., Chhetri, S., and Bhattarai, U. (2020). Immunity against COVID-19: potential role of Ayush Kwath. J. Ayurveda. Integr. Med. 13(1): 100350.
Ghosh, D. (2020). A cinnamon-derived procyanidin type-A compound: A potential candidate molecule against coronaviruses including COVID-19. Journal of Ayurveda Case Reports 3(4): 122.
Guo, J.Y., Huo, H.R., Zhao, B.S., Liu, H.B., Li, L.F., Ma, Y.Y., Guo, S.Y., and Jiang, T.L. (2006). Cinnamaldehyde reduces IL-1β-induced cyclooxygenase-2 activity in rat cerebral microvascular endothelial cells. Eur. J. Pharmacol. 537(1-3): 174–180.
Han, Y., Duan, X., Yang, L., Nilsson-Payant, B.E., Wang, P., Duan, F., Tang, X., Yaron, T.M., Zhang, T., Uhl, S., Bram, Y., Richardson, C., Zhu, J., Zhao, Z., Redmond, D., Houghton, S., Nguyen, D.T., Xu, D., Wang, X., Jessurun, J., Borczuk, A., Huang, Y., Johnson, J.L., Liu, Y., Xiang, J., Wang, H., Cantley, L.C., tenOever, B.R., Ho, D.D., Pan, F.C., Evans, T., Chen, H.J., Schwartz, R.E., and Chen, S. (2021). Identification of SARS-CoV-2 inhibitors using lung and colonic organoids. Nature 589(7841): 270–275.
Hayashi, K., Imanishi, N., Kashiwayama, Y., Kawano, A., Terasawa, K., Shimada, Y., and Ochiai, H. (2007). Inhibitory effect of cinnamaldehyde, derived from Cinnamomi cortex, on the growth of influenza A/PR/8 virus in vitro and in vivo. Antiviral Res. 74(1): 1–8.
Hotamisligil, G.S. (2006). Inflammation and metabolic disorders. Nature 444(7121): 860–867.
Howlett, A.C., and Abood, M.E. (2017). CB1 and CB2 receptor pharmacology. Adv. Pharmacol 80: 169–206.
Jena, A.B., Kanungo, N., Nayak, V., Chainy, G.B.N., and Dandapat, J. (2021). Catechin and curcumin interact with S protein of SARS-CoV2 and ACE2 of human cell membrane: insights from computational studies. Sci. Rep. 11(1): 2043.
Jha, N.K., Sharma, C., Hashiesh, H.M., Arunachalam, S., Meeran, M.N., Javed, H., Patil, C.R., Goyal, S.N., and Ojha, S. (2021). β-Caryophyllene, A Natural Dietary CB2 Receptor Selective Cannabinoid can be a Candidate to Target the Trinity of Infection, Immunity, and Inflammation in COVID-19. Front. Pharmacol. 12: 321.
Kasuga, Y., Zhu, B., Jang, K.J., and Yoo, J.S. (2021). Innate immune sensing of coronavirus and viral evasion strategies. Exp. Mol. Med. 53(5): 723–736.
Kim, D.H., Kim, C.H., Kim, M.S., Kim, J.Y., Jung, K.J., Chung, J.H., An, W.G., Lee, J.W., Yu, B.P., and Chung, H.Y. (2007). Suppression of age-related inflammatory NF-κB activation by cinnamaldehyde. Biogerontology 8(5): 545–554.
Kulkarni, S.A., Nagarajan, S.K., Ramesh, V., Palaniyandi, V., Selvam, S.P., and Madhavan, T. (2020). Computational evaluation of major components from plant essential oils as potent inhibitors of SARS-CoV-2 spike protein. J. Mol. Struct. 1221: 128823.
Kunnumakkara, A.B., Rana, V., Parama, D., Banik, K., Girisa, S., Henamayee, S., Thakur, K.K., Dutta, U., Garodia, P., Gupta, S.C., and Aggarwal, B.B. (2021). COVID-19, cytokines, inflammation, and spices: How are they related? Life Sci. 284: 119201.
Lee, S.C., Wang, S.Y., Li, C.C., and Liu, C.T. (2018). Anti-inflammatory effect of cinnamaldehyde and linalool from the leaf essential oil of Cinnamomum osmophloeum Kanehira in endotoxin-induced mice. J. Food Drug Anal. 26(1): 211–220.
Liao, B.C., Hsieh, C.W., Liu, Y.C., Tzeng, T.T., Sun, Y.W., and Wung, B.S. (2008). Cinnamaldehyde inhibits the tumor necrosis factor-α-induced expression of cell adhesion molecules in endothelial cells by suppressing NF-κB activation: Effects upon IκB and Nrf2. Toxicol. Appl. Pharmacol. 229(2): 161–171.
Lucas, K., Fröhlich-Nowoisky, J., Oppitz, N., and Ackermann, M. (2021). Cinnamon and hop extracts as potential immunomodulators for severe COVID-19 cases. Front. Plant Sci. 12: 263.
Merad, M., and Martin, J.C. (2020). Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat. Rev. Immunol 20(6): 355–362.
Nag, A., Paul, S., Banerjee, R., and Kundu, R. (2021). In silico study of some selective phytochemicals against a hypothetical SARS-CoV-2 spike RBD using molecular docking tools. Comput. Biol. Med. 137: 104818.
Narkhede, R.R., Pise, A.V., Cheke, R.S., and Shinde, S.D. (2020). Recognition of natural products as potential inhibitors of COVID-19 main protease (Mpro): In-silico evidences. Nat. Prod. Bioprospect. 10(5): 297–306.
Nathan, C. (2002). Points of control in inflammation. Nature 420(6917): 846–852.
Omar, S., Bouziane, I., Bouslama, Z., and Djemel, A. (2020). In-silico identification of potent inhibitors of COVID-19 main protease (Mpro) and angiotensin converting enzyme 2 (ACE2) from natural products: Quercetin, hispidulin, and cirsimaritin exhibited better potential inhibition than hydroxy-chloroquine against COVID-19 main protease active site and ACE2. ChemRxiv.
Paidi, R.K., Jana, M., Raha, S., McKay, M., Sheinin, M., Mishra, R.K., and Pahan, K. (2021). Eugenol, a Component of Holy Basil (Tulsi) and Common Spice Clove, Inhibits the Interaction Between SARS-CoV-2 Spike S1 and ACE2 to Induce Therapeutic Responses. J. Neuroimmune Pharmacol. 16: 743–755.
Pappas, D.E., and Hendley, J.O. (2011). The common cold and decongestant therapy. Pediatr. Rev. 32(2): 47–55.
Pham-Huy, L.A., He, H., and Pham-Huy, C. (2008). Free radicals, antioxidants in disease and health. Int. J. Biomed. Sci. 4(2): 89.
Prasanth, D.S.N.B.K., Murahari, M., Chandramohan, V., Panda, S.P., Atmakuri, L.R., and Guntupalli, C. (2020). In silico identification of potential inhibitors from Cinnamon against main protease and spike glycoprotein of SARS CoV-2. J. Biomol. Struct. Dyn. 39(13): 4618–463.
Rao, P.V., and Gan, S.H. (2014). Cinnamon: a multifaceted medicinal plant. Evid. Based Complement. Alternat. Med. 2014: 642942.
Reddy, A.M., Seo, J.H., Ryu, S.Y., Kim, Y.S., Kim, Y.S., Min, K.R., and Kim, Y. (2004). Cinnamaldehyde and 2-methoxycinnamaldehyde as NF-κB inhibitors from Cinnamomum cassia. Planta. Med. 70(09): 823–827.
Rizzuti, B., Ceballos-Laita, L., Ortega-Alarcon, D., Jimenez-Alesanco, A., Vega, S., Grande, F., Conforti, F., Abian, O., and Velazquez-Campoy, A. (2021). Sub-micromolar inhibition of SARS-CoV-2 3CLpro by natural compounds. Pharmaceuticals 14(9): 892.
Ross, J.C. (1906). CINNAMON OIL IN THE TREATMENT OF INFLUENZA. The Lancet 168(4340): 1240–1241.
Rut, W., Lv, Z., Zmudzinski, M., Patchett, S., Nayak, D., Snipas, S.J., El Oualid, F., Huang, T.T., Bekes, M., Drag, M., and Olsen, S.K. (2020). Activity profiling and structures of inhibitor-bound SARS-CoV-2-PLpro protease provides a framework for anti-COVID-19 drug design. biorxiv.
Salama, A., Mahmoud, H.A.A., Kandeil, M.A., and Khalaf, M.M. (2021). Neuroprotective role of camphor against ciprofloxacin induced depression in rats: modulation of Nrf-2 and TLR4. Immunopharmacol. Immunotoxicol. 43(3): 309–318.
Sette, A., and Crotty, S. (2021). Adaptive immunity to SARS-CoV-2 and COVID-19. Cell 184(4): 880.
Shahwar, D., Raza, M.A., Shafiq-Ur-Rehman, Abbasi, M.A., and Atta-Ur-Rahman. (2012). An investigation of phenolic compounds from plant sources as trypsin inhibitors. Nat. Prod. Res. 26(12): 1087–1093.
Singh, M., Bansal, V., and Feschotte, C. (2020). A single-cell RNA expression map of human coronavirus entry factors. Cell Rep. 32(12): 108175.
Tallei, T.E., Tumilaar, S.G., Niode, N.J., Fatimawali, Kepel, B.J., Idroes, R., Effendi, Y., Sakib, S.A., and Emran, T.B. (2020). Potential of plant bioactive compounds as SARS-CoV-2 main protease (Mpro) and spike (S) glycoprotein inhibitors: a molecular docking study. Scientifica 2020: 6307457.
Tay, M.Z., Poh, C.M., Rénia, L., MacAry, P.A., and Ng, L.F. (2020). The trinity of COVID-19: immunity, inflammation and intervention. Nat. Rev. Immunol. 20(6): 363–374.
Thimmulappa, R.K., Mudnakudu-Nagaraju, K.K., Shivamallu, C., Subramaniam, K.T., Radhakrishnan, A., Bhojraj, S., and Kuppusamy, G. (2021). Antiviral and immunomodulatory activity of curcumin: A case for prophylactic therapy for COVID-19. Heliyon 7(2): e06350.
Tragoolpua, Y., and Jatisatienr, A. (2007). Anti-herpes simplex virus activities of Eugenia caryophyllus (Spreng.) Bullock & SG Harrison and essential oil, eugenol. Phytother. Res. 21(12): 1153–1158.
Vallyathan, V., and Shi, X. (1997). The role of oxygen free radicals in occupational and environmental lung diseases. Environ. Health Perspect. 105(suppl 1): 165–177.
Zabetakis, I., Lordan, R., Norton, C., and Tsoupras, A. (2020). COVID-19: the inflammation link and the role of nutrition in potential mitigation. Nutrients 12(5): 1466.
Zhuang, M., Jiang, H., Suzuki, Y., Li, X., Xiao, P., Tanaka, T., Ling, H., Yang, B., Saitoh, H., Zhang, L., Qin, C., Sugamura, K., and Hattori, T. (2009). Procyanidins and butanol extract of Cinnamomi Cortex inhibit SARS-CoV infection. Antiviral Res. 82(1): 73–81.